Literature DB >> 19785910

Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis.

Katja Klostermann1, Fiona Crispie, Jim Flynn, William J Meaney, R Paul Ross, Colin Hill.   

Abstract

On most dairy farms teat dips are applied to the teats of cows either before or after milking in order to prevent pathogens from gaining access to the mammary gland via the teat canal. In the present experiments, a natural teat dip was developed using a fermentate containing the live bacterium Lactococcus lactis DPC 3251. This bacterium produces lacticin 3147, a two-component lantibiotic which was previously shown to effectively kill Gram-positive mastitis pathogens. Lacticin 3147 activity in the fermentate was retained at 53% of its original level following storage for 3 weeks at 4 degrees C. In the initial experiments in vitro, 105 colony-forming units/ml (cfu/ml) of either Staphylococcus aureus, Streptococcus dysgalactiae or Streptococcus uberis were introduced into the lacticin-containing fermentate. Neither Staph. aureus nor Str. dysgalactiae could be detected after 30 min or 15 min, respectively, while Str. uberis was reduced approximately 100-fold after 15 min. Following these trials, preliminary experiments were performed in vivo on teats of lactating dairy cows. In these experiments, teats were coated with each of the challenge organisms and then dipped with the lacticin-containing fermented teat dip. Following a dip contact time of 10 min, staphylococci were reduced by 80% when compared with the undipped control teat. Streptococcal challenges were reduced by 97% for Str. dysgalactiae and by 90% for Str. uberis. These trials showed that the teat dip is able to reduce mastitis pathogens on the teats of lactating cows.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19785910     DOI: 10.1017/S0022029909990239

Source DB:  PubMed          Journal:  J Dairy Res        ISSN: 0022-0299            Impact factor:   1.904


  14 in total

Review 1.  Anti-infective properties of bacteriocins: an update.

Authors:  Riadh Hammami; Benoit Fernandez; Christophe Lacroix; Ismail Fliss
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

2.  Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria.

Authors:  Catalin Iancu; Aoife Grainger; Des Field; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  Probiotics Antimicrob Proteins       Date:  2012-06       Impact factor: 4.609

Review 3.  The microbiology and treatment of human mastitis.

Authors:  Angeliki Angelopoulou; Des Field; C Anthony Ryan; Catherine Stanton; Colin Hill; R Paul Ross
Journal:  Med Microbiol Immunol       Date:  2018-01-19       Impact factor: 3.402

4.  Survival and Metabolic Activity of Pediocin Producer Pediococcus acidilactici UL5: Its Impact on Intestinal Microbiota and Listeria monocytogenes in a Model of the Human Terminal Ileum.

Authors:  Benoît Fernandez; Patricia Savard; Ismail Fliss
Journal:  Microb Ecol       Date:  2015-07-11       Impact factor: 4.552

5.  The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model.

Authors:  Clare Piper; Pat G Casey; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Int J Microbiol       Date:  2012-01-12

Review 6.  Antimicrobial Resistance: Its Surveillance, Impact, and Alternative Management Strategies in Dairy Animals.

Authors:  Chetan Sharma; Namita Rokana; Mudit Chandra; Brij Pal Singh; Rohini Devidas Gulhane; Jatinder Paul Singh Gill; Pallab Ray; Anil Kumar Puniya; Harsh Panwar
Journal:  Front Vet Sci       Date:  2018-01-08

7.  A Live Bio-Therapeutic for Mastitis, Containing Lactococcus lactis DPC3147 With Comparable Efficacy to Antibiotic Treatment.

Authors:  Michael Kitching; Harsh Mathur; James Flynn; Noel Byrne; Pat Dillon; Riona Sayers; Mary C Rea; Colin Hill; R Paul Ross
Journal:  Front Microbiol       Date:  2019-09-27       Impact factor: 5.640

8.  The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria.

Authors:  Lorraine A Draper; Paul D Cotter; Colin Hill; R Paul Ross
Journal:  BMC Microbiol       Date:  2013-09-26       Impact factor: 3.605

9.  A Novel Lactobacilli-Based Teat Disinfectant for Improving Bacterial Communities in the Milks of Cow Teats with Subclinical Mastitis.

Authors:  Jie Yu; Yan Ren; XiaoXia Xi; Weiqiang Huang; Heping Zhang
Journal:  Front Microbiol       Date:  2017-09-26       Impact factor: 5.640

Review 10.  Health Benefits of Lactic Acid Bacteria (LAB) Fermentates.

Authors:  Harsh Mathur; Tom P Beresford; Paul D Cotter
Journal:  Nutrients       Date:  2020-06-04       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.